One man with lung cancer in the brain did well on a new drug
Original title: Successful tarlatamab treatment with concomitant oral corticosteroids and anticonvulsants in small-cell lung cancer with unstable brain metastases: A case report.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is a report on just one patient, not a trial.
The short version
A new drug shrank one man's tumors, and he had no serious side effects.
What was studied. This is a report about one patient. He was a 50 year old man with small cell lung cancer that had spread to his brain. He had already tried three other treatments.
What they found. Doctors gave him a drug called tarlatamab. They also gave him a steroid, 2 mg a day, and a seizure medicine, 1000 mg a day. He finished the treatment with no serious immune reaction and no nerve or brain side effects. His tumors got smaller.
What this means, and what it doesn't
What it could mean: Brain spread often keeps people out of this kind of treatment. This report shows one man got through it safely. His doctors added two other medicines to help protect him. You can ask your care team if this drug fits your case.
What it doesn't mean: This is one person, not a study. One case cannot show that a drug works for other people. We do not know how long the tumors stayed smaller. This is early, far from routine care, and it is not a cure.
Source: PubMed, November 3, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.